etoricoxib sandoz 120 mg
sandoz - københavn - etorikoksib - tablett, filmdrasjert - 120 mg
mykofenolsyre accord 180 mg
accord healthcare b.v. - mykofenolatnatrium - enterotablett - 180 mg
mykofenolsyre accord 360 mg
accord healthcare b.v. - mykofenolatnatrium - enterotablett - 360 mg
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiske midler - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib sandoz 12.5 mg
sandoz - københavn - sunitinib - kapsel, hard - 12.5 mg
sunitinib sandoz 25 mg
sandoz - københavn - sunitinib - kapsel, hard - 25 mg
sunitinib sandoz 50 mg
sandoz - københavn - sunitinib - kapsel, hard - 50 mg
metadon pharmadone 100 mg
unimedic pharma ab - metadonhydroklorid - mikstur, oppløsning med bringebærsmak - 100 mg
metadon pharmadone 10 mg
unimedic pharma ab - metadonhydroklorid - mikstur, oppløsning med bringebærsmak - 10 mg
metadon pharmadone 15 mg
unimedic pharma ab - metadonhydroklorid - mikstur, oppløsning med bringebærsmak - 15 mg